ICD-10 Coding for Abnormal Antinuclear Antibody(M35.09, R76.0, R76.8)
Learn about the ICD-10 coding for abnormal antinuclear antibody, including documentation requirements and common pitfalls.
Complete code families applicable to Abnormal Antinuclear Antibody
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R76.0 | Raised antibody titer | Use when ANA titer is elevated with a documented pattern, but no specific autoimmune disease is confirmed. |
|
| R76.8 | Other specified abnormal immunological findings | Use when ANA pattern is specified but titer is not elevated. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAbnormal Antinuclear Antibody
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Abnormal Antinuclear Antibody.
Failing to document ANA pattern
Impact
Clinical: Inadequate clinical information for diagnosis., Regulatory: Potential non-compliance with coding standards., Financial: Risk of claim denials.
Mitigation
Educate staff on documentation standards, Use templates for consistency
Using R76.0 without specifying titer and pattern
Impact
Reimbursement: May lead to claim denials or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data representation.
Mitigation
Ensure documentation includes both titer and pattern.
Documentation of ANA results
Impact
Incomplete documentation of ANA titer and pattern.
Mitigation
Implement standardized documentation templates.
Rheumatology Progress Note
Document Abnormal Antinuclear Antibody in one step.